XP (XP) news
Recent news
XP Inc : HSBC raises target price to $32 from $24
HSBC has raised its price target for XP Inc. to $32 from $24, reflecting a significant increase in the firm’s outlook for the Brazilian financial services company. The adjustment aligns with a broader trend of analyst upgrades for XP Inc., which has seen multiple price target revisions from various…
AInvest Wire · 7d agoXeris Biopharma Holdings, Inc.: Jefferies raises target price to $12 from $10
Jefferies Financial Group analyst Glen Santangelo has raised his price target for Xeris Biopharma Holdings, Inc. (XERS) to $12 from $10, maintaining an Overweight rating for the stock . This adjustment reflects the firm’s confidence in Xeris’ recent performance and strategic progress. Xeris…
AInvest Wire · Oct 6, 2026E-commerce stocks rose in regular trading after the Brazilian presidential election outcome triggered a rally in Brazilian assets, with LITB up 4.6%, BABA gaining 3.9% and PDD rising 3.0%.
Following the first round of the Brazilian presidential election, e-commerce and fintech stocks experienced a notable rise in regular trading as investors reacted to the political developments. The stronger-than-expected performance of Flavio Bolsonaro and conservative gains in Congress fueled…
AInvest Wire · Oct 5, 2026Xeris announces inducement grants under Nasdaq listing rule 5635(C)(4)
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) announced on July 1, 2026, that its Compensation Committee granted 221,323 shares of common stock to 47 new employees under its Inducement Equity Plan. These grants were made in accordance with Rule 5635(c)(4) of NASDAQ , which permits equity awards to…
AInvest Wire · Oct 2, 2026XP Power Ltd - Comet litigation bond released
XP Power Ltd. has reached a resolution in its ongoing litigation with Comet Technologies USA, Inc., resulting in the release of a litigation bond previously held in connection with the dispute. The matter, which was brought before the Court of Appeals, has now been finalized, with the court issuing…
AInvest Wire · Sep 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.